|
|
Volumn 23, Issue 11, 2009, Pages 2140-2142
|
|
Ranibizumab: The clinician's guide to commencing, continuing, and discontinuing treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RANIBIZUMAB;
CEREBROVASCULAR ACCIDENT;
DISEASE ACTIVITY;
DISEASE COURSE;
DRUG CONTRAINDICATION;
DRUG HYPERSENSITIVITY;
DRUG INDICATION;
DRUG WITHDRAWAL;
ENDOPHTHALMITIS;
EYE EXAMINATION;
EYE INFECTION;
EYE SURGERY;
FLUORESCENCE ANGIOGRAPHY;
FOLLOW UP;
HEART INFARCTION;
HUMAN;
INTRAOCULAR PRESSURE ABNORMALITY;
LOADING DRUG DOSE;
PRACTICE GUIDELINE;
RETINA DETACHMENT;
RETINA FOVEA;
RETINA HEMORRHAGE;
RETINA MACULA AGE RELATED DEGENERATION;
SHORT SURVEY;
SUBRETINAL NEOVASCULARIZATION;
THROMBOEMBOLISM;
TREATMENT RESPONSE;
UVEITIS;
VISUAL ACUITY;
ANTIBODIES, MONOCLONAL;
CHOROIDAL NEOVASCULARIZATION;
GREAT BRITAIN;
HUMANS;
IMMUNOLOGIC FACTORS;
MACULAR DEGENERATION;
|
|
EID: 70450201592
PISSN: 0950222X
EISSN: 14765454
Source Type: Journal
DOI: 10.1038/eye.2008.241 Document Type: Short Survey |
|
Times cited : (17)
|
|
References (0)
|
